Molecular Oncology Group, Elche University Hospital, Camino Almazara 11, 03203 Elche, Spain.
J Mol Diagn. 2010 Nov;12(6):765-70. doi: 10.2353/jmoldx.2010.100039. Epub 2010 Sep 23.
The standard genetic test for Lynch syndrome (LS) frequently reveals an absence of pathogenic mutations in DNA mismatch repair genes known to be associated with LS. It was recently shown that germ line deletions in the last exons of EPCAM are involved in the etiology of LS. The aim of this study was to evaluate the prevalence of EPCAM deletions in a Spanish population and the clinical implications of deletion. Probands from 501 families suspected of having LS were enrolled in the study. Twenty-five cases with MSH2 loss were identified: 10 had mutations of MSH2, five had mutations of MSH6, and 10 did not show MSH2/MSH6 mutations. These 25 cases were analyzed for EPCAM deletions using multiplex ligation-dependent probe amplification, and deletions were mapped using long-range PCR analysis. One subject with no MSH2/MSH6 mutations had a large deletion in the EPCAM locus that extended for 8.7 kb and included exons 8 and 9. The tumor exhibited MSH2 promoter hypermethylation. EPCAM deletion analysis followed by MSH2 methylation testing of the tumor is a fast low-cost procedure that can be used to identify mutations that cause LS. We propose that this procedure be incorporated into clinical genetic analysis strategies and present a decision-support flow diagram for the diagnosis of LS.
林奇综合征(LS)的标准基因检测通常显示与 LS 相关的 DNA 错配修复基因中不存在致病性突变。最近有研究表明,EPCAM 基因最后外显子的种系缺失与 LS 的发病机制有关。本研究旨在评估西班牙人群中 EPCAM 缺失的流行率及其缺失的临床意义。本研究纳入了 501 个疑似 LS 的家系的先证者。鉴定出 25 例 MSH2 缺失的病例:10 例有 MSH2 突变,5 例有 MSH6 突变,10 例未显示 MSH2/MSH6 突变。对这 25 例患者进行 EPCAM 缺失分析,采用多重连接依赖性探针扩增,并用长距离 PCR 分析进行缺失定位。1 例无 MSH2/MSH6 突变的患者在 EPCAM 基因座存在一个 8.7 kb 的大片段缺失,包括第 8 和第 9 外显子。肿瘤存在 MSH2 启动子高甲基化。EPCAM 缺失分析联合肿瘤 MSH2 甲基化检测是一种快速、低成本的方法,可用于识别引起 LS 的突变。我们建议将该程序纳入临床遗传分析策略,并提出用于 LS 诊断的决策支持流程图。